Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14370)
All Articles published online
|
Publishing Process of This Article
|
Oct 7, 2014 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | You CR, Lee SW, Jang JW, Yoon SK. Update on hepatitis B virus infection. World J Gastroenterol 2014; 20(37): 13293-13305 [PMID: 25309066 DOI: 10.3748/wjg.v20.i37.13293] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i37/13293.htm |
| Number | Citing Articles |
| 1 |
Marlone Cunha-Silva, Fábio R.T. Marinho, Paulo F. Oliveira, Tirzah M. Lopes, Tiago Sevá-Pereira, Sonia L.S. Lorena, Jazon R.S. Almeida. Retrospective analysis of hepatitis B virus chronic infection in 247 patients: clinical stages, response to treatment and poor prognostic factors. The Brazilian Journal of Infectious Diseases 2017; 21(4): 441 doi: 10.1016/j.bjid.2017.03.019
|
| 2 |
Chang-Tai Wang, Ya-Fei Zhang, Bing-Hu Sun, Yu Dai, Hui-Lan Zhu, Yuan-Hong Xu, Meng-Ji Lu, Dong-Liang Yang, Xu Li, Zhen-Hua Zhang. Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients. World Journal of Gastroenterology 2015; 21(18): 5668-5676 doi: 10.3748/wjg.v21.i18.5668
|
| 3 |
Xiaoyu Chu, Bo Wu, Hongxia Fan, Junwei Hou, Junli Hao, Jun Hu, Baozhong Wang, Guangze Liu, Changfei Li, Songdong Meng. PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression. Antiviral Research 2016; 127: 41 doi: 10.1016/j.antiviral.2016.01.008
|
| 4 |
Yuan Hu. Advanced Techniques in Diagnostic Microbiology. 2018; : 31 doi: 10.1007/978-3-319-95111-9_2
|
| 5 |
Laura Marinela Ailioaie, Gerhard Litscher. Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(19): 7150 doi: 10.3390/ijms21197150
|
| 6 |
Frank Buchholz, Joachim Hauber. Antiviral therapy of persistent viral infection using genome editing. Current Opinion in Virology 2016; 20: 85 doi: 10.1016/j.coviro.2016.09.012
|
| 7 |
Bingtian Dong, Guorong Lyu, Yuping Chen, Guofu Lin, Huaming Wang, Ran Qin, Jionghui Gu. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis. Expert Review of Gastroenterology & Hepatology 2021; 15(9): 1077 doi: 10.1080/17474124.2021.1880894
|
| 8 |
Yoko Idobe-Fujii, Ryoko Omoso, Shinya Fujii, Hiromitsu Fujiwara, Yuki Nakamura, Takahiro Nomi, Yuichiro Sasaki, Hiroyuki Sasaki, Hajime Isomoto, Yoshikazu Murawaki. Normal values of combinational elastography in adult liver: the influence of age. Journal of Medical Ultrasonics 2021; 48(2): 207 doi: 10.1007/s10396-021-01082-6
|
| 9 |
Madiiha Bibi Mandary, Malihe Masomian, Chit Laa Poh. Impact of RNA Virus Evolution on Quasispecies Formation and Virulence. International Journal of Molecular Sciences 2019; 20(18): 4657 doi: 10.3390/ijms20184657
|
| 10 |
N. Blank, H.-M. Lorenz. Kryoglobulinämische Vaskulitiden. Zeitschrift für Rheumatologie 2016; 75(3): 303 doi: 10.1007/s00393-016-0076-4
|
| 11 |
Bryan R. Cobb, Alexandra Valsamakis, Randall T. Hayden, Donna M. Wolk, Karen C. Carroll, Yi-Wei Tang. Chronic Hepatitis B, C, and D. Microbiology Spectrum 2016; 4(4) doi: 10.1128/microbiolspec.DMIH2-0025-2015
|
| 12 |
Guangrong Dai, Yue Tan, Jingjing Liu, Beibei Yuan, Qinglian Song, Jiaming Liu, Shuixiang He. The significance of IL-28B and CK-18 M30 levels in the diagnosis of non-alcoholic steatohepatitis in SD rats. Pathology - Research and Practice 2020; 216(4): 152901 doi: 10.1016/j.prp.2020.152901
|
| 13 |
Ting Pan, Yanchao Ding, Liyang Wu, Liting Liang, Xin He, Qianwen Li, Chuan Bai, Hui Zhang. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors. European Journal of Medicinal Chemistry 2019; 166: 480 doi: 10.1016/j.ejmech.2019.01.059
|
| 14 |
Andrew D. Huber, Dallas L. Pineda, Dandan Liu, Kelsey N. Boschert, Anna T. Gres, Jennifer J. Wolf, Emily M. Coonrod, Jing Tang, Thomas G. Laughlin, Qiongying Yang, Maritza N. Puray-Chavez, Juan Ji, Kamalendra Singh, Karen A. Kirby, Zhengqiang Wang, Stefan G. Sarafianos. Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores. ACS Infectious Diseases 2019; 5(5): 750 doi: 10.1021/acsinfecdis.8b00235
|
| 15 |
Derya BAYIRLI TURAN, Tuba KURUOĞLU, Defne GÜMÜŞ, Fatma KALAYCI, Kıvanç ŞEREFHANOĞLU. Seroprevalence of HBsAg and anti-HCV for patients who admitted to third step hospital: Six-year retrospective data. Ege Tıp Dergisi 2019; 58(2): 149 doi: 10.19161/etd.502958
|
| 16 |
Hua-Jun Zhao, Yi-Fei Hu, Qiu-Ju Han, Jian Zhang. Innate and adaptive immune escape mechanisms of hepatitis B virus. World Journal of Gastroenterology 2022; 28(9): 881-896 doi: 10.3748/wjg.v28.i9.881
|
| 17 |
Feng-Ping Wu, Ying Yang, Mei Li, Yi-Xin Liu, Ya-Ping Li, Wen-Jun Wang, Juan-Juan Shi, Xin Zhang, Xiao-Li Jia, Shuang-Suo Dang. Add-on pegylated interferon augments hepatitis B surface antigen clearance <i>vs</i> continuous nucleos(t)ide analog monotherapy in Chinese patients with chronic hepatitis B and hepatitis B surface antigen ≤ 1500 IU/mL: An observational study. World Journal of Gastroenterology 2020; 26(13): 1525-1539 doi: 10.3748/wjg.v26.i13.1525
|
| 18 |
Thoraya A. Farghaly, Marwa F. Harras, Amani M.R. Alsaedi, Halima A. Thakir, Huda K. Mahmoud, Dina F. Katowah. Antiviral Activity of Pyrimidine Containing Compounds: Patent Review. Mini-Reviews in Medicinal Chemistry 2023; 23(7): 821 doi: 10.2174/1389557523666221220142911
|
| 19 |
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn. Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study). Clinical and Molecular Hepatology 2016; 22(4): 443 doi: 10.3350/cmh.2016.0037
|
| 20 |
Fenju Wei, Dongwei Kang, Srinivasulu Cherukupalli, Waleed A. Zalloum, Tao Zhang, Xinyong Liu, Peng Zhan. Discovery and optimizing polycyclic pyridone compounds as anti-HBV agents. Expert Opinion on Therapeutic Patents 2020; 30(9): 715 doi: 10.1080/13543776.2020.1801641
|
| 21 |
Yameng Pei, Chunting Wang, S. Frank Yan, Gang Liu. Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection. Journal of Medicinal Chemistry 2017; 60(15): 6461 doi: 10.1021/acs.jmedchem.6b01442
|
| 22 |
Mario Frias, Antonio Rivero-Juarez, Francisco Tellez, Monserrat Perez-Perez, Angela Camacho, Isabel Machuca, Sandra Lorenzo-Moncada, Pedro Lopez-Lopez, Antonio Rivero, Wenyu Lin. Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy. PLOS ONE 2017; 12(5): e0177141 doi: 10.1371/journal.pone.0177141
|
| 23 |
Elia Moreno-Cubero, Juan-Ramón Larrubia. Specific CD8<sup>+</sup> T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis. World Journal of Gastroenterology 2016; 22(28): 6469-6483 doi: 10.3748/wjg.v22.i28.6469
|
| 24 |
Bryan R. Cobb, Alexandra Valsamakis. Diagnostic Microbiology of the Immunocompromised Host. 2016; : 69 doi: 10.1128/9781555819040.ch3
|
| 25 |
Thoraya A. Farghaly, Amani M. R. Alsaedi, Noof A. Alenazi, Marwa F. Harras. Anti-viral activity of thiazole derivatives: an updated patent review. Expert Opinion on Therapeutic Patents 2022; 32(7): 791 doi: 10.1080/13543776.2022.2067477
|
| 26 |
Angela Jun, Sherona Bau, John S. Kim, Susanne J. Phillips. Overview of chronic hepatitis B management. The Nurse Practitioner 2025; 50(1): 7 doi: 10.1097/01.NPR.0000000000000246
|
| 27 |
Zhi-Qiang Wei, Yong-Hong Zhang, Chang-Zheng Ke, Hong-Xia Chen, Pan Ren, Yu-Lin He, Pei Hu, De-Qiang Ma, Jie Luo, Zhong-Ji Meng. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation. World Journal of Gastroenterology 2017; 23(34): 6252-6260 doi: 10.3748/wjg.v23.i34.6252
|
| 28 |
Li Ting Song, Rui Rui Liu, Hong Lin Zhai, Ya Jie Meng, Min Zhu. Molecular mechanisms of tetrahydropyrrolo[1,2-c]pyrimidines as HBV capsid assembly inhibitors. Archives of Biochemistry and Biophysics 2019; 663: 1 doi: 10.1016/j.abb.2018.12.029
|
| 29 |
Lunbiao Cui, Athina Markou, Charles W. Stratton, Evi Lianidou. Advanced Techniques in Diagnostic Microbiology. 2018; : 563 doi: 10.1007/978-3-319-95111-9_23
|
| 30 |
Jinchuan Liu, Yi Fei, Tao Zhou, Hao Ji, Ji Wu, Xiangqian Gu, Yi Luo, Jianjun Zhu, Mingxuan Feng, Ping Wan, Bijun Qiu, Yefeng Lu, Tian Yang, Pengfei Deng, Cuiping Zhou, Dongcheng Gong, Jun Deng, Feng Xue, Qiang Xia. Bile Acids Impair Vaccine Response in Children With Biliary Atresia. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.642546
|
| 31 |
Wenbiao Chen, Chenhong Lin, Lan Gong, Jianing Chen, Yan liang, Ping Zeng, Hongyan Diao. Comprehensive Analysis of the mRNA-lncRNA Co-expression Profile and ceRNA Networks Patterns in Chronic Hepatitis B. Current Genomics 2019; 20(4): 231 doi: 10.2174/1389202920666190820122126
|
| 32 |
Yunsong Li, Qun Cai, Qinxiu Xie, Yafei Zhang, Xiangling Meng, Zhenhua Zhang. Different Mechanisms May Exist for HBsAg Synthesis and Secretion During Various Phases of Chronic Hepatitis B Virus Infection. Medical Science Monitor 2017; 23: 1385 doi: 10.12659/MSM.902889
|
| 33 |
Xiao Gang Xiang, Qing Xie. IL‐35: A potential therapeutic target for controlling hepatitis B virus infection. Journal of Digestive Diseases 2015; 16(1): 1 doi: 10.1111/1751-2980.12218
|
| 34 |
Mostafa Salehi-Vaziri, Farzin Sadeghi, Amir Almasi Hashiani, Mohammad Gholami Fesharaki, Seyed Moayed Alavian. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepatitis Monthly 2016; 16(4) doi: 10.5812/hepatmon.35577
|
| 35 |
Yao‐Hui Sun, Jie Gao, Xu‐Dong Liu, Hong‐Wei Tang, Sheng‐Li Cao, Jia‐Kai Zhang, Pei‐Hao Wen, Zhi‐Hui Wang, Jie Li, Wen‐Zhi Guo, Shui‐Jun Zhang. Interaction analysis of gene variants related to one‐carbon metabolism with chronic hepatitis B infection in Chinese patients. The Journal of Gene Medicine 2021; 23(8) doi: 10.1002/jgm.3347
|
| 36 |
Mohammad Javad Khaksar, Jamal Sarvari, Zahra Faghih, Mehdi Ajorloo, Sayyad Khanizadeh. Association between IL-22 polymorphism (Rs1179251) and outcomes of HBV infection. Human Gene 2022; 33: 201059 doi: 10.1016/j.humgen.2022.201059
|
| 37 |
Nouredine Behloul, Wenjuan Wei, Sarra Baha, Zhenzhen Liu, Jiyue Wen, Jihong Meng. Effects of mRNA secondary structure on the expression of HEV ORF2 proteins in Escherichia coli. Microbial Cell Factories 2017; 16(1) doi: 10.1186/s12934-017-0812-8
|
| 38 |
Zongxing Qiu, Xianfeng Lin, Mingwei Zhou, Yongfu Liu, Wei Zhu, Wenming Chen, Weixing Zhang, Lei Guo, Haixia Liu, Guolong Wu, Mengwei Huang, Min Jiang, Zhiheng Xu, Zheng Zhou, Ning Qin, Shuang Ren, Hongxia Qiu, Sheng Zhong, Yuxia Zhang, Yi Zhang, Xiaoyue Wu, Liping Shi, Fang Shen, Yi Mao, Xue Zhou, Wengang Yang, Jim Z. Wu, Guang Yang, Alexander V. Mayweg, Hong C. Shen, Guozhi Tang. Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors. Journal of Medicinal Chemistry 2016; 59(16): 7651 doi: 10.1021/acs.jmedchem.6b00879
|
| 39 |
Pil Soo Sung, Dong Jun Park, Jung-Hee Kim, Ji Won Han, Eun Byul Lee, Gil Won Lee, Hee Chul Nam, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Eui-Cheol Shin, Su-Hyung Park, Seung Kew Yoon. Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01319
|
| 40 |
Jian Sun, Huiguo Ding, Guofeng Chen, Guiqiang Wang, Lai Wei, Jiming Zhang, Qing Xie, Mobin Wan, Hong Tang, Shijun Chen, Zhiliang Gao, Yuming Wang, Dazhi Zhang, Wenxiang Huang, Jifang Sheng, Qin Ning, Dongliang Yang, Jian Lu, Chen Pan, Yuxiu Yang, Jue Wang, Chuanzhen Sun, Qixin Wang, Jinlin Hou. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0981-5
|
| 41 |
Haiyu Wang, Ranran Xi, Jiankang Song, Biao Wen, Yuanjian Zhang, Ling Zhou, Xiaofeng Zhang, Yuan Li, Fuyuan Zhou, Youfu Zhu, Yali Ji, Qintao Lai, Qinjun He, Wenfan Luo, Tingting Qi, Miaoxia Liu, Xiaoqin Lan, Lin Dai, Jinjun Chen. Combined model with acoustic radiation force impulse to rule out high-risk varices in HBV-related cirrhosis with viral suppression. Digestive and Liver Disease 2023; 55(8): 1062 doi: 10.1016/j.dld.2023.02.007
|
| 42 |
Bing-Yi Zhang, Dan-Ping Chai, Yi-Hang Wu, Li-Peng Qiu, Yong-Yong Zhang, Zi-Hong Ye, Xiao-Ping Yu. Potential Drug Targets Against Hepatitis B Virus Based on Both Virus and Host Factors. Current Drug Targets 2019; 20(16): 1636 doi: 10.2174/1389450120666190729115646
|
| 43 |
Jong Chul Kim, Hye Young Lee, Ah Ram Lee, Mehrangiz Dezhbord, Da Rae Lee, Seong Ho Kim, Juhee Won, Soree Park, Na Yeon Kim, Jae Jin Shin, Sang Gyune Kim, Young Seok Kim, Jeong-Ju Yoo, Kyun-Hwan Kim. Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient. Biomedicines 2022; 10(2): 282 doi: 10.3390/biomedicines10020282
|
| 44 |
Zhuocai Wei, Jie Tan, Xinhua Cui, Min Zhou, Yunhou Huang, Ning Zang, Zhaoni Chen, Wanxing Wei. Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents. Molecules 2020; 25(15): 3359 doi: 10.3390/molecules25153359
|
| 45 |
Madina Karimova, Niklas Beschorner, Werner Dammermann, Jan Chemnitz, Daniela Indenbirken, Jan-Hendrik Bockmann, Adam Grundhoff, Stefan Lüth, Frank Buchholz, Julian Schulze zur Wiesch, Joachim Hauber. CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X. Scientific Reports 2015; 5(1) doi: 10.1038/srep13734
|
| 46 |
Victor C. K. Lo, Harry L. A. Janssen. Hepatitis B Virus in Human Diseases. Molecular and Translational Medicine 2016; : 325 doi: 10.1007/978-3-319-22330-8_15
|
| 47 |
Qiao-Li Lv, Gui-Hua Wang, Shu-Hui Chen, Lei Hu, Xue Zhang, Guo Ying, Chong-Zhen Qin, Hong-Hao Zhou. In Vitro and in Vivo Inhibitory Effects of Glycyrrhetinic Acid in Mice and Human Cytochrome P450 3A4. International Journal of Environmental Research and Public Health 2015; 13(1): 84 doi: 10.3390/ijerph13010084
|
| 48 |
Jung Hun Kim, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo, Eileen L. Yoon, Seong Hee Kang. Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers. Antimicrobial Agents and Chemotherapy 2022; 66(8) doi: 10.1128/aac.00275-22
|
| 49 |
Ana R. Gomes, Ana S. Pires, Fernanda M. F. Roleira, Elisiário J. Tavares-da-Silva. The Structural Diversity and Biological Activity of Steroid Oximes. Molecules 2023; 28(4): 1690 doi: 10.3390/molecules28041690
|
| 50 |
Joshua D. Long, Stephanie M. Rutledge, Meghan E. Sise. Autoimmune Kidney Diseases Associated with Chronic Viral Infections. Rheumatic Disease Clinics of North America 2018; 44(4): 675 doi: 10.1016/j.rdc.2018.06.006
|
| 51 |
Dalia Morales-Arraez, Felicitas Diaz-Flores, Ana Alonso, Antonia de Vera, Alejandro Jimenez, Jose A. Garcia Dopico, Enrique Quintero, Manuel Hernández-Guerra. Patients with suboptimal hepatitis B virus diagnostic characterization are at risk of liver fibrosis progression. European Journal of Gastroenterology & Hepatology 2020; 32(3): 426 doi: 10.1097/MEG.0000000000001527
|
| 52 |
Romina Mancinelli, Luigi Rosa, Antimo Cutone, Maria Stefania Lepanto, Antonio Franchitto, Paolo Onori, Eugenio Gaudio, Piera Valenti. Viral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin. Molecules 2020; 25(8): 1997 doi: 10.3390/molecules25081997
|
| 53 |
Citrawati Dyah Kencono Wungu, Mochamad Amin, S. Eriaty N. Ruslan, Priyo Purwono, Ulfa Kholili, Ummi Maimunah, Poernomo Setiawan, Maria Lusida, Soetjipto Soetjipto, Retno Handajani. Association between host TNF‑α, TGF‑β1, p53 polymorphisms, HBV X gene mutation, HBV viral load and the progression of HBV‑associated chronic liver disease in Indonesian patients. Biomedical Reports 2019; doi: 10.3892/br.2019.1239
|
| 54 |
Akshar Radhakrishnan, Merry Kashyap, Amrita Sinharay, S. Jyotshna, Senthilkumar Rajagopal. Recent Developments in Nanomaterial-based Sensing of Human Pathogens. 2024; : 93 doi: 10.1016/B978-0-443-18574-8.00006-6
|
| 55 |
Cyriac A Philips, Rizwan Ahamed, Jinsha K Abduljaleel, Sasidharan Rajesh, Philip Augustine. Critical Updates on Chronic Hepatitis B Virus Infection in 2021. Cureus 2021; doi: 10.7759/cureus.19152
|
| 56 |
Atsuya Yamashita, Yuusuke Fujimoto, Mayumi Tamaki, Andi Setiawan, Tomohisa Tanaka, Kaori Okuyama-Dobashi, Hirotake Kasai, Koichi Watashi, Takaji Wakita, Masaaki Toyama, Masanori Baba, Nicole De Voogd, Shinya Maekawa, Nobuyuki Enomoto, Junichi Tanaka, Kohji Moriishi. Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay. Marine Drugs 2015; 13(11): 6759 doi: 10.3390/md13116759
|
| 57 |
Haiyu Wang, Biao Wen, Xianyi Chang, Qiaoping Wu, Weiqun Wen, Fuyuan Zhou, Yabing Guo, Yali Ji, Yixiu Gu, Qintao Lai, Qinjun He, Junying Li, Jinjun Chen, Jinlin Hou. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. Journal of Hepatology 2021; 74(3): 584 doi: 10.1016/j.jhep.2020.09.034
|
| 58 |
Man-Fung Yuen, Ding-Shinn Chen, Geoffrey M. Dusheiko, Harry L. A. Janssen, Daryl T. Y. Lau, Stephen A. Locarnini, Marion G. Peters, Ching-Lung Lai. Hepatitis B virus infection. Nature Reviews Disease Primers 2018; 4(1) doi: 10.1038/nrdp.2018.35
|
| 59 |
Jana K Dickter, Justine A Ross. Bictegravir/Emtricitabine/Tenofovir Alafenomide for the Treatment of HIV/Hepatitis B Virus Co-infection in Patients with Cancer and Transplant Recipients. Infectious Diseases 2023; 2(1): 31 doi: 10.17925/ID.2023.2.1.31
|